Clinical Trial Update: Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating liposomal annamycin for acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Liposomal Annamycin (annamycin liposome)

Snippet

Sponsor: Moleculin Biotech, Inc. | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED